Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-19 4:16 PM View:  | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 121,020 | -- | -- | (100%) 121.02K to 0 | |
| 23-Apr-19 4:15 PM View: | Li Yvonne See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 65,895 | -- | -- | (100%) 65.89K to 0 | |
| 23-Apr-19 4:15 PM View: | Stagg Robert See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 28,917 | -- | -- | (100%) 28.92K to 0 | |
| 23-Apr-19 4:15 PM View: | Lasersohn Jack W Director | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 185,709 | -- | -- | (11%) 1.69M to 1.5M | |
| 23-Apr-19 4:15 PM View: | Lewicki John A. President and CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 142,534 | -- | -- | (100%) 142.53K to 0 | |
| 23-Apr-19 4:15 PM View: | Lasersohn Jack W Director | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 1,500,200 | -- | -- | (100%) 1.5M to 0 | |
| 23-Apr-19 4:15 PM View: | Karsen Perry A Director | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 80,500 | -- | -- | (100%) 80.5K to 0 | |
| 23-Apr-19 4:16 PM View: | Hager Alicia J. SVP and General Counsel | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 39,488 | -- | -- | (100%) 39.49K to 0 | |
| 23-Apr-19 4:15 PM View: | Pakianathan Deepika Director | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 2,010,540 | -- | -- | (100%) 2.01M to 0 | |
| 26-Dec-18 4:35 PM View: | Gurney Austin See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 24-Dec-18 | Market Sale | 11,117 | $0.60 | $6,669.09 | (14%) 77.92K to 66.81K | (60%) |
| 11-Oct-18 6:57 PM View: | Gurney Austin See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-18 | Market Sale | 1,156 | $2.01 | $2,323.56 | (1%) 79.08K to 77.92K | 54% |
| 11-Oct-18 7:00 PM View: | Stagg Robert SVP, Clinical R&D | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-18 | Market Sale | 927 | $2.01 | $1,863.27 | (2%) 41.6K to 40.67K | 54% |
| 11-Oct-18 6:59 PM View: | Li Yvonne See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-18 | Market Sale | 927 | $2.02 | $1,872.54 | (2%) 60.66K to 59.73K | 54% |
| 11-Oct-18 6:55 PM View: | Lewicki John A. President & CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-18 | Market Sale | 1,156 | $2.01 | $2,323.56 | (< 1%) 156.51K to 155.35K | 54% |
| 11-Oct-18 6:56 PM View: | Hager Alicia J. SVP & General Counsel | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-18 | Market Sale | 1,156 | $2.02 | $2,335.12 | (2%) 52.91K to 51.75K | 54% |
| 10-Oct-18 7:42 PM View: | Gurney Austin See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-18 | Market Sale | 1,686 | $2.13 | $3,589.33 | (2%) 80.77K to 79.08K | 56% |
| 10-Oct-18 7:41 PM View: | Stagg Robert SVP, Clinical R&D | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-18 | Market Sale | 1,686 | $2.13 | $3,589.33 | (4%) 43.28K to 41.6K | 56% |
| 10-Oct-18 7:44 PM View: | Li Yvonne See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-18 | Market Sale | 1,229 | $2.13 | $2,616.30 | (2%) 61.89K to 60.66K | 56% |
| 10-Oct-18 7:40 PM View: | Lewicki John A. President & CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-18 | Market Sale | 2,296 | $2.13 | $4,887.95 | (1%) 158.81K to 156.51K | 56% |
| 10-Oct-18 7:38 PM View: | Hager Alicia J. SVP & General Counsel | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-18 | Market Sale | 1,686 | $2.13 | $3,589.16 | (3%) 54.6K to 52.91K | 56% |
| 13-Feb-19 10:00 PM View: | Lewicki John A. President & CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 06-Aug-18 | Gift | 11,793 | -- | -- | 8% 155.35K to 167.15K | |
| 13-Feb-19 10:00 PM View: | Lewicki John A. President & CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 06-Aug-18 | Gift | 11,793 | -- | -- | (7%) 167.15K to 155.35K | |
| 26-Apr-18 6:13 PM View: | Stagg Robert SVP, Clinical R&D | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-18 | Market Sale | 4,051 | $2.68 | $10,848.20 | (9%) 47.33K to 43.28K | 65% |
| 26-Apr-18 6:14 PM View: | Li Yvonne See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-18 | Market Sale | 5,062 | $2.68 | $13,554.50 | (8%) 64.95K to 59.89K | 65% |
| 26-Apr-18 6:13 PM View: | Lewicki John A. President & CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-18 | Market Sale | 4,557 | $2.68 | $12,202.30 | (3%) 159.36K to 154.81K | 65% |
| 26-Apr-18 6:11 PM View: | Hager Alicia J. SVP & General Counsel | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-18 | Market Sale | 4,051 | $2.68 | $10,847.80 | (7%) 58.65K to 54.6K | 65% |
| 26-Apr-18 6:12 PM View: | Gurney Austin See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-18 | Market Sale | 4,051 | $2.68 | $10,847.80 | (5%) 80.82K to 76.77K | 65% |
| 28-Feb-18 4:45 PM View: | Karsen Perry A Director | Oncomed Pharmaceuticals Inc (OMED) | 26-Feb-18 | Grant | 70,500 | -- | -- | 705% 10.0K to 80.5K | |
| 12-Oct-17 6:35 PM View: | Lewicki John A. President | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-17 | Market Sale | 1,248 | $4.24 | $5,294.62 | (< 1%) 160.61K to 159.36K | 78% |
| 12-Oct-17 6:34 PM View: | Gurney Austin See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-17 | Market Sale | 1,248 | $4.24 | $5,295.06 | (2%) 82.06K to 80.82K | 78% |
| 12-Oct-17 6:35 PM View: | Hastings Paul J Chairman & CEO | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-17 | Market Sale | 1,398 | $4.24 | $5,931.04 | (< 1%) 402.43K to 401.03K | 78% |
| 12-Oct-17 6:36 PM View: | Patel Sunil See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-17 | Market Sale | 1,248 | $4.24 | $5,295.06 | (2%) 69.58K to 68.34K | 78% |
| 12-Oct-17 6:33 PM View: | Hager Alicia J. SVP & General Counsel | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-17 | Market Sale | 1,248 | $4.24 | $5,294.62 | (2%) 59.9K to 58.65K | 78% |
| 10-Oct-17 7:28 PM View: | Lewicki John A. President | Oncomed Pharmaceuticals Inc (OMED) | 07-Oct-17 | Grant | 25,000 | -- | -- | 18% 135.61K to 160.61K | |
| 10-Oct-17 7:28 PM View: | Patel Sunil See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 07-Oct-17 | Grant | 25,000 | -- | -- | 56% 44.58K to 69.58K | |
| 10-Oct-17 7:27 PM View: | Hager Alicia J. SVP & General Counsel | Oncomed Pharmaceuticals Inc (OMED) | 07-Oct-17 | Grant | 18,334 | -- | -- | 44% 41.56K to 59.9K | |
| 10-Oct-17 7:27 PM View: | Gurney Austin See Remarks | Oncomed Pharmaceuticals Inc (OMED) | 07-Oct-17 | Grant | 18,334 | -- | -- | 29% 63.73K to 82.06K | |
| 07-Jun-17 6:18 PM View: | Karsen Perry A Director | Oncomed Pharmaceuticals Inc (OMED) | 05-Jun-17 | Market Purchase | 10,000 | $3.46 | $34,588.00 | 100% 0 to 10.0K | (73%) |
| 26-May-17 11:57 AM View: | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 26-May-17 | Market Sale | 9,580 | $3.70 | $35,463.20 | (7%) 130.6K to 121.02K | 75% |
| 26-May-17 5:51 PM View: | Lasersohn Jack W Director | Oncomed Pharmaceuticals Inc (OMED) | 25-May-17 | Market Purchase | 34,614 | $3.37 | $116,639.00 | 2% 1.65M to 1.69M | (72%) |
| 26-May-17 11:57 AM View: | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 24-May-17 | Market Sale | 4,300 | $3.72 | $15,977.90 | (3%) 134.9K to 130.6K | 75% |
| 25-May-17 6:33 PM View: | Lasersohn Jack W Director | Oncomed Pharmaceuticals Inc (OMED) | 23-May-17 | Market Purchase | 20,000 | $3.55 | $71,000.00 | 1% 1.63M to 1.65M | (74%) |
| 22-May-17 8:16 PM View: | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 19-May-17 | Market Sale | 7,487 | $3.70 | $27,711.60 | (5%) 142.39K to 134.9K | 75% |
| 18-May-17 6:43 PM View: | Lasersohn Jack W Director | Oncomed Pharmaceuticals Inc (OMED) | 16-May-17 | Market Purchase | 23,507 | $3.49 | $82,060.60 | 1% 1.61M to 1.63M | (73%) |
| 18-May-17 4:49 PM View: | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 16-May-17 | Market Sale | 6,900 | $3.58 | $24,714.40 | (5%) 149.29K to 142.39K | 74% |
| 15-May-17 6:42 PM View: | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 11-May-17 | Disposition (other) | 2,010,000 | -- | -- | (93%) 2.16M to 149.29K | |
| 15-May-17 6:42 PM View: | Root Jonathan D Director | Oncomed Pharmaceuticals Inc (OMED) | 11-May-17 | Acquisition (other) | 55,929 | -- | -- | 3% 2.1M to 2.16M | |
| 06-Feb-18 10:00 PM View: | Lewicki John A. President | Oncomed Pharmaceuticals Inc (OMED) | 10-May-17 | Gift | 10,437 | -- | -- | 7% 159.36K to 169.8K | |
| 06-Feb-18 10:00 PM View: | Lewicki John A. President | Oncomed Pharmaceuticals Inc (OMED) | 10-May-17 | Gift | 10,437 | -- | -- | (6%) 169.8K to 159.36K | |
| 25-Apr-17 6:12 PM View: | Hastings Paul J Chairman & CEO Director | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-17 | Grant | 45,000 | -- | -- | 13% 357.43K to 402.43K |
